Bioactivity:

Ezeprogind (AZP-2006) disulfate is an orally active neurotrophic inducer. Ezeprogind disulfate targets all causes of neurodegeneration and is not only aiming at markers such as Abeta protein or tau protein[1]. Ezeprogind disulfate is a potent neuroprotectant and can be used for the research of neurological disorders, including progressive supranuclear palsy (PSP), tauopathies, alzheimer�s and parkinson�s diseases, et al[1][2]. [1]. Alzprotect Strengthens Its Intellectual Property Portfolio for Its First-in-Class Clinical Stage Drug Ezeprogind[2]. A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP

CAS nr:

1616671-13-6

Purity:

98%

Molecular Weight:

624,81

SMILES:

N/A

Formula:

C25H48N6O8S2

Pathway:

Neuroscience

Target:

Beta Amyloid